Skip to main content
Vicarious Surgical Inc. logo

Vicarious Surgical Inc. — Investor Relations & Filings

Ticker · RBOT ISIN · US92561V1098 US Manufacturing
Open in API
Filings indexed 660 across all filing types
Latest filing 2022-11-09 Director's Dealing
Country US United States of America
Listing US RBOT

About Vicarious Surgical Inc.

https://www.vicarioussurgical.com/

Vicarious Surgical Inc. is a medical robotics company developing a next-generation surgical platform for minimally invasive procedures. Its core product, the Vicarious Surgical System, is designed to operate through a single port, requiring an incision as small as 1.5 cm for a camera and two robotic instruments to access the abdomen. The system's proprietary technology features human-like robotic arms engineered to replicate the full range of a surgeon's upper body movements, providing enhanced dexterity and control. A key design feature is that all robotic motion occurs inside the patient, which aims to maximize maneuverability and reduce the risk of external collisions. The platform provides surgeons with an immersive 3D, 360-degree view from inside the patient, creating a sense of being transported to the surgical site. The system consists of a Patient Cart and a Surgeon Console, from which the surgeon operates the robot to increase surgical efficiency and precision.

Recent filings

Filing Released Lang Actions
Director's Dealing 2022
Director's Dealing
2022-11-09 English
QUARTERLY REPORT
Interim / Quarterly Report Q3 2022
2022-11-07 English
CURRENT REPORT
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 7, 2022, reporting the results of operations and financial condition for the third quarter ended September 30, 2022. It includes a press release announcing quarterly results and a business update. The document explicitly states it is a Current Report on Form 8-K and includes a press release as an exhibit. The Form 8-K is used for current reports and is not a full quarterly or annual report. The content corresponds to an Earnings Release (ER) as it announces quarterly financial results and business updates. The document length is under 5,000 characters but contains the actual press release text, not just a notice of publication, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is Earnings Release (ER).
2022-11-07 English
PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act of 1933. It relates to an at-the-market offering of Class A common stock by Vicarious Surgical Inc. The text includes detailed information about the offering, the sales agreement with Cowen and Company, the use of proceeds, risk factors, and other disclosures typical of a capital raising document. There is no financial statement or earnings data presented, nor is it an annual or quarterly report, audit report, or earnings release. The document is clearly an update on capital raising activities and financing terms. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the actual prospectus supplement, not just an announcement of a report publication.
2022-10-28 English
Director's Dealing 2022
Director's Dealing
2022-10-28 English
Regulatory Filings 2022
Regulatory Filings
2022-10-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.